Last, we report that transgene-free iMPCs can robustly engraft limb muscles of DMD mice, efficiently restoring dystrophin expression in approximately 3–10% of myofibers and contributing cells to the muscle stem cell pool, thereby unveiling potential utility for cell-based therapies. The gene discussed is DMD; the disease is Duchenne muscular dystrophy.